A Study of GEn-1124 in Subjects with Acute Respiratory Distress Syndrome (ARDS)

Recruiting

Phase 2

A Study of GEn-1124 in Subjects with Acute Respiratory Distress Syndrome (ARDS)A Study of GEn-1124 in Subjects with Acute Respiratory Distress Syndrome (ARDS)

Sponsor:

GEn1E Lifesciences

Code:

NCT05795465

Conditions

Respiratory Distress Syndrome, Acute

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

GEn-1124

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by GEn1E Lifesciences on 2024-11-18.